Condition

Hemorrhagic Stroke

ClinicalTrials.gov condition label

Clinical trials7

Recruiting0

Common interventions8

Lead sponsors shown7

Clinical trials

7 shown

Post Market Clinical Follow-up of CODMAN CERTAS Programmable ValveNCT05397106 · 2023-01-24

ACTIVE_NOT_RECRUITING

Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in PregnancyNCT05121415 · 2021-10-23

COMPLETED

Mapping the Natural History of Parenychymal and Cerebral Perfusion Changes in Acute Ischemic and Hemorrhagic StrokesNCT05865795 · 2021-10-01

COMPLETED

Esmolol for the Treatment of Hypertension After Intracerebral Hemorrhage Study (ETHICHS)NCT03743103 · 2019-04-18

TERMINATED

Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-ComtéNCT02626377 · 2015-10-01

TERMINATED

Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain InjuryNCT02018406 · 2011-07-05

UNKNOWN

Observational Study on Determinants of Dementia After StrokeNCT01334749 · 2011-04-01

ACTIVE_NOT_RECRUITING

Common interventions

Brevibloc, 10 Mg/mL Intravenous SolutionDRUG1CODMAN CERTAS Plus Programmable ValveDEVICE1Combination injection of EPO and G-CSFDRUG1Information booklet receiptOTHER1Injection of normal salineDRUG1Nitroprusside, SodiumDRUG1SNP analysis of the DNAGENETIC1Support provided by social workerBEHAVIORAL1

Leading sponsors

Asfendiyarov Kazakh National Medical University1Centre Hospitalier Universitaire de Besancon1Cristália Produtos Químicos Farmacêuticos Ltda.1Integra LifeSciences Corporation1Ludwig-Maximilians - University of Munich1Wake Forest University Health Sciences1Yonsei University1

Trial status mix

ACTIVE_NOT_RECRUITING2

COMPLETED2

TERMINATED2

UNKNOWN1

Phase mix

NA1

PHASE11

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.